Contact Dr. Jeffrey Velotta
510-752-1105
Dr. Jeffrey Velotta
Kaiser Permanente Oakland Medical Center
Oakland,
CA
Dr. Jeffrey Velotta is a renowned thoracic surgeon at Kaiser Permanente Oakland Medical Center, serving pleural mesothelioma patients in the Bay Area and on the West Coast. He also leads breakthrough research in new ways to improve mesothelioma patient outcomes.
- Thoracic Surgeon
- Pleural Specialist
- Contributing Writer
- Speciality:
-
Thoracic Surgery
- Procedures Offered:
-
Cardiothoracic Surgery
Extrapleural Pneumonectomy
Minimally Invasive Surgery
Pleurectomy/Decortication - Conditions Treated:
-
Esophageal Cancer
Lung Cancer
Pleural Mesothelioma - Gender:
-
Male
- Language:
-
English
Primary Location
Free Mesothelioma Treatment Guide
- Speciality:
-
Thoracic Surgery
- Procedures Offered:
-
Cardiothoracic Surgery
Extrapleural Pneumonectomy
Minimally Invasive Surgery
Pleurectomy/Decortication - Conditions Treated:
-
Esophageal Cancer
Lung Cancer
Pleural Mesothelioma - Gender:
-
Male
- Language:
-
English
Primary Location
Kaiser Permanente Oakland Medical Center3600 Broadway, Oakland, CA 94611
DirectionsAbout Dr. Jeffrey Velotta
Dr. Velotta is a top mesothelioma doctor at Kaiser Permanente in Oakland, California. He’s also a clinical assistant surgical professor at the University of California San Francisco School of Medicine and a renowned mesothelioma researcher.
“I currently have ongoing studies pertaining to novel ways to provide better pain relief after thoracic surgery and multimodality treatment of mesothelioma,” Dr. Velotta tells us. His research focuses on novel and minimally invasive lung cancer surgery techniques.
He researches image-guided surgeries and develops surgery improvements. He also works on mesothelioma treatment center regionalization and multimodal therapy research.
Medical Education & Experience
- University of California San Francisco School of Medicine (Clinical Assistant Surgical Professor)
- Brigham and Women’s Hospital (Fellowship)
- UCLA Medical Center (Residency)
- George Washington University Medical School (M.D.)
Associations, Awards & Recognition
- Society of Asian Academic Surgeons Mid-Career Faculty Award, 2025
- UCSF Medicine’s Academy of Medical Educators Excellence in Mentorship Award, 2024
- Reversing Health Disparities in Lung Cancer Research Award, 2023
- American College of Surgeons
- Society of Thoracic Surgeons
Why Choose Dr. Jeffrey Velotta for Pleural Mesothelioma
Thoracic surgeon Dr. Jeffrey Velotta is paving the way for mesothelioma surgery advancements at Kaiser Permanente Oakland Medical Center. He has years of experience in cardiac and thoracic surgery. His dedication has garnered recognition through several awards for his research and mentorship.
Velotta’s work focuses on minimally invasive lung and esophageal surgery, image-guided surgical techniques for small lung nodules and multimodality mesothelioma care. He remains committed to providing excellent care and the best surgical services for mesothelioma patients.
Publications of Dr. Jeffrey Velotta
- Yang, M.Z. et al. (2024, September 16). Representativeness of Patients With Lung Cancer in an Integrated Health Care Delivery System.
- Banks, C.K. et al. (2022, January 28). Salvage Resection After Immunotherapy in Refractory Malignant Pleural Mesothelioma.
- Okabe, K. et al. (2021, October 1). The Results of Multimodal Treatment With Extrapleural Pneumonectomy for Female Epithelioid Malignant Pleural Mesothelioma. Journal of Thoracic Oncology.
- Ossowski, S. et al. (2021, October 1). Improving Outcomes in Malignant Pleural Mesothelioma in an Integrated Health System. Journal of Thoracic Oncology.
- Ely, S. et al. (2021, March 19). Effect of thoracic surgery regionalization on long-term survival after lung cancer resection. The Journal of Thoracic and Cardiovascular Surgery.
- Ely, S. et al. (2020, March 14). Regionalization of Lung Cancer Surgery Improves Outcomes in an Integrated Health Care System. The Annals of Thoracic Surgery.
Watch Our Free Mesothelioma Webinars
Find Active Mesothelioma Clinical Trials
Mesothelioma Trust Funds
